A. Nechepurenko, N. Ilov, S. S. Durmanov, P. Shugaev, Andrey V. Ivanchenko, I. Suchkov, Khosni A. Bsharat, Andrey M. Lukin, Lyudmila G. Medyanсeva, V. Povarov
{"title":"止血剂“血凝块”在减少口袋血肿中的应用。PEGAS研究的设计:多中心临床试验","authors":"A. Nechepurenko, N. Ilov, S. S. Durmanov, P. Shugaev, Andrey V. Ivanchenko, I. Suchkov, Khosni A. Bsharat, Andrey M. Lukin, Lyudmila G. Medyanсeva, V. Povarov","doi":"10.17816/cardar70497","DOIUrl":null,"url":null,"abstract":"Pocket hematoma (PH) is a common complication of pacemaker implantations which prolongs hospitalization and may demand surgical revision in some cases. According to the data from different researchers PH rate varies from 2 to 7%. It depends on number of factors including a need for anticoagulation therapy. We present a review of design of multicenter clinical trial evaluating safety and efficacy of application of hemostatic agent Haemoblock for pocket hematoma reduction in patients taking oral anticoagulants.","PeriodicalId":33934,"journal":{"name":"Journal of Cardiac Arrhythmias","volume":"107 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of Hemostatic Agent “Haemoblock” for Pocket Hematoma Reduction. Design of the PEGAS study: a Multicenter Clinical Trial\",\"authors\":\"A. Nechepurenko, N. Ilov, S. S. Durmanov, P. Shugaev, Andrey V. Ivanchenko, I. Suchkov, Khosni A. Bsharat, Andrey M. Lukin, Lyudmila G. Medyanсeva, V. Povarov\",\"doi\":\"10.17816/cardar70497\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pocket hematoma (PH) is a common complication of pacemaker implantations which prolongs hospitalization and may demand surgical revision in some cases. According to the data from different researchers PH rate varies from 2 to 7%. It depends on number of factors including a need for anticoagulation therapy. We present a review of design of multicenter clinical trial evaluating safety and efficacy of application of hemostatic agent Haemoblock for pocket hematoma reduction in patients taking oral anticoagulants.\",\"PeriodicalId\":33934,\"journal\":{\"name\":\"Journal of Cardiac Arrhythmias\",\"volume\":\"107 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiac Arrhythmias\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17816/cardar70497\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiac Arrhythmias","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/cardar70497","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Application of Hemostatic Agent “Haemoblock” for Pocket Hematoma Reduction. Design of the PEGAS study: a Multicenter Clinical Trial
Pocket hematoma (PH) is a common complication of pacemaker implantations which prolongs hospitalization and may demand surgical revision in some cases. According to the data from different researchers PH rate varies from 2 to 7%. It depends on number of factors including a need for anticoagulation therapy. We present a review of design of multicenter clinical trial evaluating safety and efficacy of application of hemostatic agent Haemoblock for pocket hematoma reduction in patients taking oral anticoagulants.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
